Highlights
In Fuchs endothelial corneal dystrophy, the need for keratoplasty is clinically important but often difficult to predict using examination findings alone.
A 2026 study in Ophthalmology reports that genomic risk profiling, specifically CTG18.1 repeat expansion status combined with a disease-specific polygenic risk score, predicts risk of progression to keratoplasty.
